Chang DY, Ma WL, & Lu YS. (2021). Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press.
Chicago Style (17th ed.) CitationChang DY, Ma WL, and Lu YS. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press, 2021.
MLA (9th ed.) CitationChang DY, et al. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.